Maria Hägg Olofsson

2.1k total citations
26 papers, 1.7k citations indexed

About

Maria Hägg Olofsson is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Maria Hägg Olofsson has authored 26 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 13 papers in Oncology and 5 papers in Cell Biology. Recurrent topics in Maria Hägg Olofsson's work include Cell death mechanisms and regulation (7 papers), Ubiquitin and proteasome pathways (6 papers) and Cancer-related Molecular Pathways (6 papers). Maria Hägg Olofsson is often cited by papers focused on Cell death mechanisms and regulation (7 papers), Ubiquitin and proteasome pathways (6 papers) and Cancer-related Molecular Pathways (6 papers). Maria Hägg Olofsson collaborates with scholars based in Sweden, United States and Germany. Maria Hägg Olofsson's co-authors include Stig Linder, Mårten Fryknäs, Rolf Larsson, Pádraig D’Arcy, Slavica Brnjic, Xiaonan Zhang, Walid Fayad, Kristina Lindsten, Behnam Sadeghi and Michelandrea De Cesare and has published in prestigious journals such as Nature Medicine, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Maria Hägg Olofsson

26 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maria Hägg Olofsson Sweden	17	1.2k	472	247	197	197	26	1.7k
Xiaonan Zhang Sweden	21	1.2k 1.0×	475 1.0×	383 1.6×	202 1.0×	171 0.9×	65	1.9k
Linda Rickardson Sweden	18	705 0.6×	290 0.6×	219 0.9×	125 0.6×	103 0.5×	28	1.1k
Hong Wu China	28	2.2k 1.9×	526 1.1×	173 0.7×	144 0.7×	124 0.6×	61	2.9k
Shingo Dan Japan	26	1.4k 1.2×	493 1.0×	294 1.2×	107 0.5×	213 1.1×	95	2.3k
Jean‐Pierre Gillet United States	16	1.0k 0.9×	876 1.9×	231 0.9×	85 0.4×	81 0.4×	29	1.7k
Brandon J. Aubrey Australia	10	1.2k 1.1×	568 1.2×	328 1.3×	127 0.6×	102 0.5×	17	1.8k
Helena Pópulo Portugal	13	1.2k 1.0×	518 1.1×	344 1.4×	158 0.8×	138 0.7×	21	1.9k
Ana Janic Australia	10	1.3k 1.1×	590 1.3×	361 1.5×	110 0.6×	144 0.7×	13	1.8k
Ramzi M. Mohammad United States	28	1.1k 1.0×	788 1.7×	249 1.0×	83 0.4×	134 0.7×	74	1.9k
Wynne Aherne United Kingdom	27	1.5k 1.3×	509 1.1×	270 1.1×	153 0.8×	301 1.5×	58	2.3k

Countries citing papers authored by Maria Hägg Olofsson

Since Specialization

Citations

This map shows the geographic impact of Maria Hägg Olofsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Hägg Olofsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Hägg Olofsson more than expected).

Fields of papers citing papers by Maria Hägg Olofsson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Hägg Olofsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Hägg Olofsson. The network helps show where Maria Hägg Olofsson may publish in the future.

Co-authorship network of co-authors of Maria Hägg Olofsson

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Hägg Olofsson. A scholar is included among the top collaborators of Maria Hägg Olofsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Hägg Olofsson. Maria Hägg Olofsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stafford, William C., Xiaoxiao Peng, Maria Hägg Olofsson, et al.. (2018). Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy. Science Translational Medicine. 10(428). 164 indexed citations

Zhang, Xiaonan, Paola Pellegrini, Amir Ata Saei, et al.. (2018). The deubiquitinase inhibitor b-AP15 induces strong proteotoxic stress and mitochondrial damage. Biochemical Pharmacology. 156. 291–301. 24 indexed citations

Wang, Xin, Magdalena Mazurkiewicz, Ellin‐Kristina Hillert, et al.. (2016). The proteasome deubiquitinase inhibitor VLX1570 shows selectivity for ubiquitin-specific protease-14 and induces apoptosis of multiple myeloma cells. Scientific Reports. 6(1). 26979–26979. 133 indexed citations

Cheng, Qing, Helena Wållberg, Frank Leigh Lu, et al.. (2016). Preclinical PET imaging of EGFR levels: pairing a targeting with a non-targeting Sel-tagged Affibody-based tracer to estimate the specific uptake. EJNMMI Research. 6(1). 58–58. 14 indexed citations

Fryknäs, Mårten, Xiaonan Zhang, Ulf Bremberg, et al.. (2016). Iron chelators target both proliferating and quiescent cancer cells. Scientific Reports. 6(1). 38343–38343. 57 indexed citations

Senkowski, Wojciech, Xiaonan Zhang, Maria Hägg Olofsson, et al.. (2015). Three-Dimensional Cell Culture-Based Screening Identifies the Anthelmintic Drug Nitazoxanide as a Candidate for Treatment of Colorectal Cancer. Molecular Cancer Therapeutics. 14(6). 1504–1516. 118 indexed citations

Zhang, Xiaonan, Mårten Fryknäs, E Hernlund, et al.. (2014). Induction of mitochondrial dysfunction as a strategy for targeting tumour cells in metabolically compromised microenvironments. Nature Communications. 5(1). 3295–3295. 194 indexed citations

Samén, Erik, Fabian Arnberg, Frank Leigh Lu, et al.. (2013). Metabolism of Epidermal Growth Factor Receptor Targeting Probe [¹¹C]PD153035: Impact on Biodistribution and Tumor Uptake in Rats. Journal of Nuclear Medicine. 54(10). 1804–1811. 6 indexed citations

Wållberg, Helena, Qing Cheng, Frank Leigh Lu, et al.. (2012). HER2-Positive Tumors Imaged Within 1 Hour Using a Site-Specifically ¹¹C-Labeled Sel-Tagged Affibody Molecule. Journal of Nuclear Medicine. 53(9). 1446–1453. 25 indexed citations

10.

Cheng, Qing, Frank Leigh Lu, Maria Hägg Olofsson, et al.. (2012). Combining [11C]-AnxA5 PET Imaging with Serum Biomarkers for Improved Detection in Live Mice of Modest Cell Death in Human Solid Tumor Xenografts. PLoS ONE. 7(8). e42151–e42151. 11 indexed citations

11.

D’Arcy, Pádraig, Slavica Brnjic, Maria Hägg Olofsson, et al.. (2012). Abstract 2941: Inhibition of proteasome deubiquitinating activity as a novel cancer therapy. Cancer Research. 72(8_Supplement). 2941–2941. 1 indexed citations

12.

Cheng, Qing, Frank Leigh Lu, Maria Hägg Olofsson, et al.. (2012). Site-specifically 11C-labeled Sel-tagged annexin A5 and a size-matched control for dynamic in vivo PET imaging of protein distribution in tissues prior to and after induced cell death. Biochimica et Biophysica Acta (BBA) - General Subjects. 1830(3). 2562–2573. 9 indexed citations

13.

D’Arcy, Pádraig, Slavica Brnjic, Maria Hägg Olofsson, et al.. (2011). Inhibition of proteasome deubiquitinating activity as a new cancer therapy. Nature Medicine. 17(12). 1636–1640. 411 indexed citations

14.

Fayad, Walid, Linda Rickardson, Caroline Haglund, et al.. (2011). Identification of Agents that Induce Apoptosis of Multicellular Tumour Spheroids: Enrichment for Mitotic Inhibitors with Hydrophobic Properties. Chemical Biology & Drug Design. 78(4). 547–557. 37 indexed citations

15.

Hernlund, E, Maria Hägg Olofsson, Walid Fayad, et al.. (2011). The phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 is effective in inhibiting regrowth of tumour cells after cytotoxic therapy. European Journal of Cancer. 48(3). 396–406. 9 indexed citations

16.

Brnjic, Slavica, Maria Hägg Olofsson, Aleksandra Mandic Havelka, & Stig Linder. (2010). Chemical biology suggests a role for calcium signaling in mediating sustained JNKactivation during apoptosis. Molecular BioSystems. 6(5). 767–774. 34 indexed citations

17.

Linder, Stig, Maria Hägg Olofsson, Richard Herrmann, & Engı̇n Ulukaya. (2010). Utilization of cytokeratin-based biomarkers for pharmacodynamic studies. Expert Review of Molecular Diagnostics. 10(3). 353–359. 48 indexed citations

18.

Fayad, Walid, Slavica Brnjic, Daniel Berglind, et al.. (2009). Restriction of cisplatin induction of acute apoptosis to a subpopulation of cells in a three‐dimensional carcinoma culture model. International Journal of Cancer. 125(10). 2450–2455. 31 indexed citations

19.

Fayad, Walid, Mårten Fryknäs, Slavica Brnjic, et al.. (2009). Identification of a Novel Topoisomerase Inhibitor Effective in Cells Overexpressing Drug Efflux Transporters. PLoS ONE. 4(10). e7238–e7238. 37 indexed citations

20.

Olofsson, Maria Hägg, Aleksandra Mandic Havelka, Slavica Brnjic, Maria C. Shoshan, & Stig Linder. (2008). Charting calcium-regulated apoptosis pathways using chemical biology: role of calmodulin kinase II. SHILAP Revista de lepidopterología. 8(1). 2–2. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact